Furthermore, the clinical heterogeneity of PD and the overlapping clinical spectrum with atypical parkinsonisms (AP), namely MSA and AP with tauopathies (AP-Tau), often prevent a proper diagnosis and management of patients, especially in early phases8. The gene discussed is MAPT; the disease is tauopathy.